{
  "id": 18107842,
  "title": "MET inhibition exploits conserved regulatory dependencies in malignant rhabdoid tumors",
  "url": "https://urgent.news/2026/11/04/met-inhibition-exploits-conserved-regulatory-dependencies-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.03.763704v1?rss=1"
  },
  "original_language": "en",
  "account": "Malignant rhabdoid tumors (MRTs) are aggressive, genetically uniform childhood cancers driven by universal dysregulation of the SWI/SNF complex. The mechanisms sustaining these tumors and their actionable molecular dependencies have been elusive. To address this knowledge gap, researchers generated a comprehensive single-cell multi-omic dataset encompassing anatomically and molecularly diverse MRTs. Employing this resource, they identified candidate tumor-specific dependencies and functionally validated them in vitro and in vivo using patient-derived models. The study revealed that distinct malignant subpopulations are spatially organized within complex topological landscapes, shaped by interactions with the tumor microenvironment, including stromal and immune cells. The researchers identified recurrent transcriptional metaprograms common across patients and molecular subtypes, including a novel shared core rhabdoid program and another program linked to extracellular matrix interactions, predominantly present in areas where tumor tissue interfaces with surrounding stroma. Mechanistically, the core shared rhabdoid program was found to be regulated by a circuit involving the transcription factors TCF12, ZNF148, and CHD2. Building upon these findings, the researchers performed a targeted drug screen in patient-derived MRT models, ultimately identifying HGF/MET signaling as a potential therapeutic target in extrarenal rhabdoid tumors. Pharmacologic inhibition of MET proved effective in sensitive models, leading to complete remission in vivo using an approved drug. Notably, MET expression in primary tumors correlated with treatment response, suggesting that MET inhibition could serve as a biomarker for patient stratification, enabling personalized therapy for this lethal pediatric malignancy. This research not only elucidates the molecular architecture of MRTs but also unveils a targetable signaling axis with immediate clinical potential, paving the way for precision medicine in the treatment of this devastating disease.",
  "summary": "Malignant rhabdoid tumors (MRTs) are lethal, yet genomically simple childhood cancers characterised by universal SWI/SNF dysregulation. Despite this shared molecular framework, the regulatory programs sustaining MRTs and how they wire actionable dependencies, remain poorly defined. Here, we integrated single-cell multi-omic profiling and spatial transcriptomics across anatomically and molecularly…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}